Brivanib
Sponsors
Bristol-Myers Squibb, M.D. Anderson Cancer Center, Hunan Cancer Hospital
Conditions
Advanced Non-small Cell Lung CancerCarcinoma, HepatocellularColorectal AdenocarcinomaColorectal CancerGastric/Esophageal AdenocarcinomaGastro-Intestinal CancerHepato Cellular Carcinoma (HCC)Hepatocellular Carcinoma
Phase 1
MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors
CompletedNCT00207103
Start: 2004-09-30End: 2008-09-30Updated: 2008-11-04
A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors
CompletedNCT00390936
Start: 2007-10-31End: 2010-03-31Updated: 2011-01-25
A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)
CompletedNCT00435669
Start: 2007-09-30End: 2008-06-30Updated: 2009-01-22
A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)
CompletedNCT00437437
Start: 2000-05-31End: 2013-02-28Updated: 2013-06-21
A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction
CompletedNCT00437424
Start: 2007-07-31End: 2010-06-30Updated: 2011-05-04
Phase I/II Combination With Irinotecan- Erbitux
CompletedNCT00594984
Start: 2008-05-31End: 2012-12-31Updated: 2015-11-04
Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)
CompletedNCT01046864
Start: 2010-02-28End: 2014-06-30Updated: 2014-09-16
Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
CompletedNCT01540461
Start: 2012-03-31End: 2013-11-30Updated: 2014-07-08
A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer
NCT03895788
Start: 2019-01-14End: 2020-03-31Target: 24Updated: 2019-03-29
Phase 2
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
CompletedNCT00633789
Start: 2008-06-30End: 2012-12-31Updated: 2015-10-09
Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF
TerminatedNCT01367275
Start: 2011-08-31End: 2013-11-30Updated: 2020-09-03
Phase 3
Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment
CompletedNCT00825955
Start: 2009-02-17End: 2017-08-25Updated: 2019-10-09
First Line Hepato Cellular Carcinoma (HCC)
CompletedNCT00858871
Start: 2009-05-31End: 2013-09-30Updated: 2016-10-17
Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
CompletedNCT00908752
Start: 2009-07-20End: 2018-01-26Updated: 2019-12-02
Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment
TerminatedNCT01108705
Start: 2010-05-31End: 2013-10-31Updated: 2015-10-12